BioMarin Pharmaceutical | BMRN - 流动负债

金融业

USD

USD 7.59B

现金及等价物

USD 1.31B

USD 161.56M

USD 3.95B

USD 759.03M

USD 604.24M

USD 198.39M

USD -24.17M

3.04K

EPS每股收益

USD 0.46

股本和储备

USD 6.09B

USD 713.01M

债务利息支出

USD 2.78M

USD 17.85M

USD 597.18M

USD 11.03B

USD -46.57M

USD 676.18M

USD 198.39M

普通股股本

USD 192.3M

19.24

USD -26.32M

USD 875M

销售和管理费用

USD 322.21M

USD 1.3B

贸易债权人

USD 759.03M

应收帐款人

USD 908.21M

	流动负债	更改		日
Acadia Pharmaceuticals	USD 277.11M		79.47M	2025-12
Agios Pharmaceuticals	USD 82.21M		7.45M	2025-12
Alnylam Pharmaceuticals	USD 1.47B		89.13M	2025-12
Amgen	USD 25.49B		3.7B	2025-12
Bayer	EUR 32.58B		3.63B	2025-12
Biogen	USD 3.35B		59.4M	2025-12
BioMarin Pharmaceutical	USD 759.03M		39.41M	2025-12
Gilead Sciences	USD 11.81B		485M	2025-12
Incyte	USD 1.52B		176.44M	2025-12
Insmed	USD 468.87M		51.66M	2025-12
Ionis Pharmaceuticals	USD 783M		120.46M	2025-12
Moderna	USD 1.99B		306M	2025-12
Neurocrine Biosciences	USD 743.4M		105.4M	2025-12
PTC Therapeutics	USD 968.43M		102.18M	2025-12
Puma Biotechnology	USD 82.73M		3.63M	2025-09
Regeneron Pharmaceuticals	USD 4.37B		56.7M	2025-12
Roche Holding	CHF 28B		421M	2025-12
Sangamo BioSciences	USD 47.66M		1.9M	2025-06
Sanofi	EUR 28.35B		9.32B	2025-12
Sarepta Therapeutics	USD 1.1B		173.86M	2025-12
Ultragenyx Pharmaceutical	USD 340.02M		46.78M	2025-09
United Therapeutics	USD 560.6M		14.3M	2025-12
Vertex Pharmaceuticals	USD 3.86B		614.1M	2025-12